BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37326760)

  • 1. Capillary rarefaction: a missing link in renal and cardiovascular disease?
    Steegh FMEG; Keijbeck AA; de Hoogt PA; Rademakers T; Houben AJHM; Reesink KD; Stehouwer CDA; Daemen MJAP; Peutz-Kootstra CJ
    Angiogenesis; 2024 Feb; 27(1):23-35. PubMed ID: 37326760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression.
    Kida Y
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Kidney Injury, Microvascular Rarefaction, and Estimated Glomerular Filtration Rate in Kidney Transplant Recipients.
    Doreille A; Azzi F; Larivière-Beaudoin S; Karakeussian-Rimbaud A; Trudel D; Hébert MJ; Dieudé M; Patey N; Cardinal H
    Clin J Am Soc Nephrol; 2021 Mar; 16(3):415-426. PubMed ID: 33648972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.
    Kida Y; Tchao BN; Yamaguchi I
    Pediatr Nephrol; 2014 Mar; 29(3):333-42. PubMed ID: 23475077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of peritubular capillary rarefaction in kidneys of cats with chronic kidney disease.
    Paschall RE; Quimby JM; Cianciolo RE; McLeland SM; Lunn KF; Elliott J
    J Vet Intern Med; 2023 Mar; 37(2):556-566. PubMed ID: 36807589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAS protein activator-like 2 (RASAL2) initiates peritubular capillary rarefaction in hypoxic renal interstitial fibrosis.
    Zhang Y; Yang Y; Hu X; Wei B; Shen Q; Shi C; Chen P
    Transl Res; 2024 Jul; 269():14-30. PubMed ID: 38453052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcirculatory function deteriorates with advancing stages of chronic kidney disease independently of arterial stiffness and atherosclerosis.
    Schoina M; Loutradis C; Memmos E; Dimitroulas T; Pagkopoulou E; Doumas M; Karagiannis A; Garyfallos A; Papagianni A; Sarafidis P
    Hypertens Res; 2021 Feb; 44(2):179-187. PubMed ID: 32728149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal capillary and arteriolar changes in patients with chronic kidney disease.
    Bosch A; Scheppach JB; Harazny JM; Raff U; Eckardt KU; Schmieder RE; Schneider MP
    Microvasc Res; 2018 Jul; 118():121-127. PubMed ID: 29559377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced CT imaging in patients with chronic kidney disease.
    von Stillfried S; Apitzsch JC; Ehling J; Penzkofer T; Mahnken AH; Knüchel R; Floege J; Boor P
    Angiogenesis; 2016 Oct; 19(4):525-35. PubMed ID: 27582011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Renal Peritubular Capillaries in Canine and Feline Chronic Kidney Disease.
    Nakamura R; Yabuki A; Ichii O; Mizukawa H; Yokoyama N; Yamato O
    J Comp Pathol; 2018 Apr; 160():79-83. PubMed ID: 29729724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity.
    Querfeld U; Mak RH; Pries AR
    Clin Sci (Lond); 2020 Jun; 134(12):1333-1356. PubMed ID: 32542397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal capillary rarefaction as a marker of microvascular damage in patients with rheumatoid arthritis: Association with inflammation and disorders of the macrocirculation.
    Anyfanti P; Gkaliagkousi E; Triantafyllou A; Zabulis X; Dolgyras P; Galanopoulou V; Aslanidis S; Douma S
    Microcirculation; 2018 Jul; 25(5):e12451. PubMed ID: 29734516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGFR2 insufficiency enhances phosphotoxicity and undermines Klotho's protection against peritubular capillary rarefaction and kidney fibrosis.
    Shi M; Maique JO; Cleaver O; Moe OW; Hu MC
    Am J Physiol Renal Physiol; 2023 Jan; 324(1):F106-F123. PubMed ID: 36395384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease.
    Burkhardt D; Bartosova M; Schaefer B; Grabe N; Lahrmann B; Nasser H; Freise C; Schneider A; Lingnau A; Degenhardt P; Ranchin B; Sallay P; Cerkauskiene R; Malina M; Ariceta G; Schmitt CP; Querfeld U
    PLoS One; 2016; 11(11):e0166050. PubMed ID: 27846250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of peritubular capillary density with glomerular volume and kidney function in living kidney donors.
    van der Weijden J; De Hoogt PA; Leufkens MME; Keijbeck AA; van Goor H; van den Heuvel MC; Cleutjens JPM; Moers C; Snoeijs MG; Navis GJ; van Londen M; Nolte IM; Berger SP; De Borst MH; Peutz-Kootstra CJ
    J Nephrol; 2023 Sep; 36(7):2111-2124. PubMed ID: 37768545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension.
    Frost S; Nolde JM; Chan J; Joyson A; Gregory C; Carnagarin R; Herat LY; Matthews VB; Robinson L; Vignarajan J; Prentice D; Kanagasingam Y; Schlaich MP
    Sci Rep; 2021 Jan; 11(1):1001. PubMed ID: 33441624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease.
    Schoina M; Loutradis C; Theodorakopoulou M; Dimitroulas T; Triantafillidou E; Doumas M; Karagiannis A; Garyfallos A; Papagianni A; Sarafidis P
    Microcirculation; 2021 Feb; 28(2):e12665. PubMed ID: 33064902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillin-1-enriched microenvironment drives endothelial injury and vascular rarefaction in chronic kidney disease.
    Li L; Liao J; Yuan Q; Hong X; Li J; Peng Y; He M; Zhu H; Zhu M; Hou FF; Fu H; Liu Y
    Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary Rarefaction Associates with Albuminuria: The Maastricht Study.
    Martens RJ; Henry RM; Houben AJ; van der Kallen CJ; Kroon AA; Schalkwijk CG; Schram MT; Sep SJ; Schaper NC; Dagnelie PC; Muris DM; Gronenschild EH; van der Sande FM; Leunissen KM; Kooman JP; Stehouwer CD
    J Am Soc Nephrol; 2016 Dec; 27(12):3748-3757. PubMed ID: 27160406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.